期刊文献+

超声微泡在心脏疾病诊治中的应用进展 被引量:2

Application progress of ultrasound microbubble in diagnosis and treatment of cardiac diseases
下载PDF
导出
摘要 超声微泡因具有微创性、高安全性、实时动态显像的优势,已被广泛应用于临床造影中,可为心脏疾病的诊断提供有价值的信息。随着分子研究的发展,超声微泡的靶向成像、基因治疗已在动物实验中被深入研究,这为心脏疾病未来的诊治提供了新方向。本文就超声微泡在心脏疾病诊治中的应用进展作一综述。 Ultrasound microbubbles have been widely used in contrast echocardiography because of their advantages of non-invasion,high-safety,and real-time dynamic imaging,providing valuable information for the diagnosis of heart diseases.With the development of molecular research,targeted imaging and gene therapy of ultrasound microbubbles have been deeply studied in animal experiments,which provides a new direction for the future diagnosis and treatment of cardiac diseases.This paper reviews the application of ultrasound microbubbles in the diagnosis and treatment of cardiac diseases.
作者 谭妍迪 赵云 周军 TAN Yan-di;ZHAO Yun;ZHOU Jun(Three Gorges University Medical School,Yichang 443002,China;Department of Ultrasound,the First College of Clinical Medical Sciences,China Three Gorges University)
出处 《天津医药》 CAS 北大核心 2019年第1期104-108,共5页 Tianjin Medical Journal
基金 湖北省重点实验室开放基金(2017KXNO6)
关键词 血管造影术 综述 超声微泡 心脏疾病 治疗 angiography review ultrasound microbubble cardiac disease treatment
  • 相关文献

参考文献2

二级参考文献13

  • 1Voulgari C, Papadogiaimis I), Tentolouris IN. Diabeticcardiomyopathy: from the patliophysioiogy of the cardiacmyocytes to current diagnosis and management strategies[J].Vast: Health Risk Manag, 2010, 6:883- 903. 1)01: 10.2147/VHKM.S11681.
  • 2Villanueva FS, Abraham JA, Schreiner GF, et al. Myocardialcontrast echocardiography can be used to assess themicrovascular response to vascular endothelial growtli factor-121[J]. Circulation, 2002, 105(6):759-765.
  • 3Martinez G, Di Giacomo C, Sorrenti V, et al. Fibroblast growthf actor-2 and transforming growth factor- beta I immunostainingin rat brain after cerebral postischemic reperfusionfJJ. JNeurosci Res, 2001, 63(2):136-142.
  • 4Xiao J, Lv Y, Lin S, et al. Cardiac protection by hasic ?ibroi)lastgrowth factor from ischernia/reperfusion- induced injury indiabetic ratsjjj. liiol Pharm Bull, 2010, 33(3):444-449.
  • 5Zhao YZ. Tian XQ, Zhang M, et a). Functional and pathologicalimprovements of the hearts in diabetes model by the <*om!>ine(ltherapy of hF(^F-loaded nanoparticles with ultrasound-targetedmicrohubhle deslruc:tion[J]. J Control Release. 2014. 186:22-31. DOI: 10.1016/j.jconrel.2014.04.054.
  • 6Jiang Y, Wei N, Lu T, et al. Intranasal brain-derivedneurotrophic factor protects brain from ischemic insult viamodulating local inflammation in rats[J|. Neuroscience, 2011.172:398-405. 1)01: 10.1016/j .neuroscience,2010.10.054.
  • 7Beenken A. Mohainmadi M. The FGF family: biology,pathophysiology and therapy|J]. Nat Rev Drug Discov, 2009. 8(3):235-253. 1101: 10.1 038/nrd2792.
  • 8Lin ZV, Li XK, Lin Y, et al. Protective effects of non-mitogenic human acidic film山last growth factor on hydrt>genperoxide-imluced damage to t^ardiomyocytes in vitro[J]. WorldJ Gastroenterol, 2005, 11(35):5492-5497.
  • 9Ischakov R, Adler-Abramovich I>. Buzhansky L, et al. Peptide-hased hydrogel nanoparticles as effective drug delivery agents[J|. Bioorg Med Chem, 2013, 21(12):3517-22. l)OI: 10.1016/j.1狐 2013.03.012.
  • 10Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Rerentadvances on chitosan-hased micro- and nanoparticles in (inig<lelivery[Jj. J Control Release, 2004. 100(1):5-28.

共引文献18

同被引文献24

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部